Micro-X Limited

OTC-MCRXF
OTCMKTS
Healthcare Medical Devices
Global Rank
#33063
Country Rank
#801
Market Cap
34.07 M
Price
0.02
Change (%)
39.58%
Volume
2,500

Micro-X Limited's latest marketcap:

34.07 M

As of 08/14/2025, Micro-X Limited's market capitalization has reached $34.07 M. According to our data, Micro-X Limited is the 33063th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 34.07 M
Revenue (ttm) 8.74 M
Net Income (ttm) -6,673,061
Shares Out 0
EPS (ttm) -0.01
Forward PE 0.00
Ex-Dividend Date n/a
Earnings Date 08/28/2025
Market Cap Chart
Data Updated: 08/14/2025

Micro-X Limited's yearly market capitalization.

Micro-X Limited has seen its market value drop from $50.44 M to $34.07 M since 2015, representing a total decrease of 32.46% and an annual compound decline rate (CAGR) of 4.00%.
Date Market Cap($) Change (%) Global Rank
08/14/2025 $34.07 M 12.18% 33063
12/31/2024 $30.31 M -18.25% 46311
12/29/2023 $37.08 M -18.34% 44656
12/30/2022 $45.41 M -46.78% 42974
12/31/2021 $85.31 M -13.34% 41042
12/31/2020 $98.45 M 183.06% 37932
12/31/2019 $34.78 M 10.3% 35355
12/28/2018 $31.53 M -34.97% 34046
12/29/2017 $48.49 M 15.91% 32602
12/29/2016 $41.83 M -17.06% 30649

Company Profile

About Micro-X Limited

Micro-X Limited is an innovative company specializing in the design, development, and manufacturing of advanced X-ray technology for healthcare and security markets. Leveraging its proprietary cold cathode X-ray technology, the company operates globally, serving regions such as Australia, the United States, Asia-Pacific, Europe, the Middle East, and Africa.

Key Products and Solutions

  • Carbon Nanotube-Based X-Ray Products: Core X-ray tube and high-voltage generator components.
  • Rover Plus: A mobile medical imaging system delivering full medical performance.
  • Head CT: Designed for stroke diagnosis in ambulances or retrieval aircraft.
  • ARGUS: Advanced stand-off imaging technology.
  • Checkpoints: Modular passenger self-screening checkpoints for airports.
  • Baggage Scanner: A CT-based scanner for passenger self-screening checkpoints.

Founded: 2011
Headquarters: Tonsley, Australia

Frequently Asked Questions

  • What is Micro-X Limited's (OTC-MCRXF) current market cap?
    As of 08/14/2025, Micro-X Limited (including the parent company, if applicable) has an estimated market capitalization of $34.07 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Micro-X Limited global market capitalization ranking is approximately 33063 as of 08/14/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.